(Q40165074)

18 September 2017

title

Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin (English)

1 reference

18 September 2017

0 references

1 reference

Yi Liu

1

1 reference

18 September 2017

Bo Huang

2

1 reference

18 September 2017

Ye Yuan

3

1 reference

18 September 2017

Wei Gong

4

1 reference

18 September 2017

Han Xiao

5

1 reference

18 September 2017

Dong Li

6

1 reference

18 September 2017

Zhi-Rui Yu

7

1 reference

18 September 2017

Feng-Hua Wu

8

1 reference

18 September 2017

Gui-Mei Zhang

9

1 reference

18 September 2017

Zuo-Hua Feng

10

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

International Journal of Cancer

18 September 2017

published in

1 reference

18 September 2017

volume

121

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

184-192

1 reference

Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.

18 September 2017

cites work

1 reference

Inhibitory Effect of Recombinant Fibronectin Polypeptides on the Adhesion of Liver‐metastatic Lymphoma Cells to Hepatic Sinusoidal Endothelial Cells and Tumor Invasion

21 January 2018

1 reference

Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma

21 January 2018

1 reference

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22644

1 reference

18 September 2017

1 reference